Context Therapeutics announces bispecific antibody clinical candidate to treat CLDN6+ cancers
News Direct
Dec 06, 2022
–News Direct–
Contact Details
Proactive Investors USA
Proactive Investors USA
+1 347-449-0879
na-editorial@proactiveinvestors.com
View original content to download multimedia: https://newsdirect.com/news/context-therapeutics-announces-bispecific-antibody-clinical-candidate-to-treat-cldn6-cancers-478676962